Investigation of the clinical significance of the expression of immunohistochemical biomarkers Enhancer of zeste homolog 2 and Forkhead box M1 in localized prostate cancer tissue: A Greek retrospective study
Sufficient immunoexpression of EZH2, ductal carcinoma component, and neoplastic proliferation in the seminal vesicles, apex and neck of the prostate gland correlates with elevated risks of recurrence and mortality. Clinicians should use these criteria for appropriate patient referrals, and a multicenter trial could provide accurate classifications.
Authors
- Ourania Mpatsi
- Andreas C. Lazaris (ORCID: https://orcid.org/0000-0002-8118-7780)
- Iliana Mani (ORCID: https://orcid.org/0000-0002-9971-5174)
- Dimitrios Goutas (ORCID: https://orcid.org/0000-0003-1996-5884)
- Harikleia Gakiopoulou
- Christos Alamanis
- Sotirios Koubardas
- Evangelia Krikou
Institutions
- National and Kapodistrian University of Athens (GR)
- Laiko General Hospital of Athens (GR)
- Hospital Agioi Anargyroi (GR)
- Hippocration General Hospital (GR)
Publication Details
- Journal
- Asian journal of urology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1016/j.ajur.2024.09.007
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National and Kapodistrian University of Athens